Expression profiling of core genes in NSCLC patients revealed significantly elevated expression of CCNA2, CDK1, and EGFR, whereas FOS, CCL2, and CAV1 exhibited reduced expression. The gene discussed is CCL2; the disease is non-small cell lung carcinoma.